Podoconiosis patients’ willingness to pay for treatment services in Northwest Ethiopia: potential for cost recovery by Abreham Tamiru et al.
Tamiru et al. BMC Public Health 2014, 14:259
http://www.biomedcentral.com/1471-2458/14/259RESEARCH ARTICLE Open AccessPodoconiosis patients’ willingness to pay for
treatment services in Northwest Ethiopia:
potential for cost recovery
Abreham Tamiru1*, Girmay Tsegay1, Moges Wubie1, Molla Gedefaw2, Sara Tomczyk3 and Fasil Tekola-Ayele4Abstract
Background: Podoconiosis is non-filarial elephantiasis of the lower legs. It is more commonly found in tropical
Africa, Central and South America, and northwest India. In Ethiopia, a few non-governmental organizations provide
free treatment to podoconiosis patients, but sustainability of free treatment and scale-up of services to reach the
huge unmet need is challenged by resource limitations. We aimed to determine podoconiosis patient’s willingness
to pay (WTP) for a treatment package (composed of deep cleaning of limbs with diluted antiseptic solution, soap,
and water, bandaging, application of emollient on the skin, and provision of shoes), and factors associated with
WTP in northwestern Ethiopia.
Methods: A cross-sectional study was conducted among randomly selected untreated podoconiosis patients
(n = 393) in Baso Liben woreda, northwestern Ethiopia. The contingent valuation method was used with a
pre-tested interviewer-administered questionnaire.
Results: The majority of podoconiosis patients (72.8%) were willing to pay for treatment services. The median WTP
amount was 64 Birr (US$ 3.28) per person per year. More than one-third of patients (36.7%) were willing to pay at
least half of the full treatment cost and 76.2% were willing to pay at least half of the cost of shoes. A multivariate
analysis showed that having a higher monthly income, being a woman, older age, being aware of the role of shoes
to prevent podoconiosis, and possession of a functional radio were significantly associated with higher odds of
WTP.
Conclusions: The considerable WTP estimates showed that podoconiosis treatment could improve sustainability
and service utilization. A subsidized cost recovery scheme could reduce treatment costs and more feasibility
integrate podoconiosis treatment service with other NTDs and the government’s primary health care system.
Keywords: Willingness to pay (WTP), Podoconiosis, Neglected tropical disease, Health policy, Global health,
Treatment, Contingent valuation method, EthiopiaBackground
Podoconiosis is a geo-chemical neglected tropical dis-
ease (NTD) affecting genetically susceptible people that
have prolonged barefoot exposure to red clay soil. It
leads to elephantiasis or swelling of the lower legs [1-4].
Podoconiosis is common in more than ten countries
across tropical Africa, Central and South America and
northwest India [1,5,6]. In endemic areas, podoconiosis-* Correspondence: abrish80@gmail.com
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cial stigmatization, physical disability, and economic
impairment [7-9].
At the early clinical stages, podoconiosis can be treated
using simple and effective measures: regular washing of
feet with soap and water, application of emollient on the
skin, elevation of the leg at night, compression therapy
with elastic bandages, and regular use of footwear [10].
However, podoconiosis has been given little attention by
health policy makers and implementing health institutions
in endemic countries. For example, in Ethiopia, approxi-
mately one million patients are affected by podoconiosis,Ltd. This is an Open Access article distributed under the terms of the Creative
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vices. These treatment services are provided by non-
governmental non-profit organizations [11]. In northern
Ethiopia, most of the prevention and treatment services
are provided nearly free of charge by the International
Orthodox Christian Charities (IOCC) Podoconiosis Treat-
ment and Prevention Project at six treatment clinics [12].
During the past three years, the demand for the treatment
has increased and surpassed IOCC’s resources. As a con-
sequence, a large number of podoconiosis patients are on
a waiting list. In western and southern Ethiopia, other
donor-driven podoconiosis treatment programs have also
faced financial challenges that have limited the sustainable
provision of treatment and scale-up of services to meet
the unmet needs [11].
Treatment cost-recovery options may add to the sus-
tainability of treatment services and allow the integration
of podoconiosis treatment in the primary health care sys-
tem of government health facilities. In the present study,
we determined the willingness to pay (WTP) of podoco-
niosis patients in northern Ethiopia to understand whether
cost-recovery can be proposed as an option for sustainable
treatment and control of podoconiosis.Methods
Study area
The study was conducted in Baso Liben woreda (a gov-
ernment administrative region in Ethiopia, equivalent to
a district), one of the 20 woredas in East Gojam Zone,
northwestern Ethiopia. Its main town has an elevation
of 2,211 meters above sea level. Baso Liben woreda’s
projected population size in the year 2013 was estimated
to be 152,598 people, of which 95% live in rural areas and
depend on subsistence farming for a living [13].Study design and sampling
This was a cross-sectional institution-based study. The
source of the study participants was podoconiosis
patients in Baso Liben woreda on the waiting list of
IOCC’s Podoconiosis Treatment and Prevention Project
(n = 3,800). Using sample size calculation for a single
population proportion and assuming a 95% CI (z = 1.96)
for the margin of error to be no wider than 5%, and a
maximum single proportion (50%), the minimum sam-
ple size becomes 384 individuals. We added 9 individ-
uals on top of this for contingency. Adult podoconiosis
patients were selected from the waiting list using the
simple random sampling technique. First, the names of
individuals on the waiting list at the IOCC Baso Liben
treatment site were written on pieces of papers. Next,
the pieces of papers were folded and mixed, and 393
study participants were randomly chosen to be included
in the study.Data collection tool and procedures
Data were collected using a structured questionnaire
that had two parts. Part one included questions that
assessed the demographic, clinical, shoe wearing, and
socio-economic characteristics of the study participants.
Part two assessed the study participants’ WTP for podo-
coniosis treatment services. To assess WTP, the contin-
gent valuation method (CVM) was used. CVM is a
questionnaire-based method used to elicit the monetary
value a person is willing to pay for a health care service
[14]. First, a detailed explanation was given to all partic-
ipants about the components of the treatment services
provided by IOCC’s Podoconiosis Treatment and Pre-
vention Project, frequency of visits and schedules, types
of health workers involved, and infrastructure of health
facilities available for the treatment services. The treat-
ment components include deep cleaning of limbs with
diluted antiseptic solution, soap, and water, bandaging,
application of emollient on the skin, and provision of
shoes. Next, the respondents were asked a ‘yes’ or ‘no’
question about whether or not they would agree to pay
for these treatment services. If the response was ‘no’,
the respondents were asked the reason. If the response
was ‘yes’, the respondents were asked an open-ended
contingent valuation question about the maximum
amount that they would be willing to pay for the treat-
ment services per person per year. Following this open-
ended question, every study participant was asked a
series of binary (i.e. dichotomous choice) format ques-
tions based on the ‘bidding game’ method [14]. In the
‘bidding game’ method, respondents are asked whether
or not they would be willing to pay a given amount and
they are then asked follow-up questions about higher or
lower amounts [14]. In this study, the series of ques-
tions was: (a) Are you willing to pay the full IOCC cost
of treatment for podoconiosis (330 Birr or US$ 16.92
per person per year)? (if no, go to b); (b) Are you willing
to pay 3/4th of the full cost (248 Birr or US$ 12.72 per
person per year)? (if no, go to c); (c) Are you willing to
pay half of the full cost (165 Birr or US$ 8.46 per person
per year)? Shoes are the main component of podoconio-
sis treatment and prevention. Therefore, affected indi-
viduals were asked similar questions about WTP for
shoes given other services are provided for free starting
with the IOCC cost of shoe production for one person
(250 Birr or US$ 12.82). Eight nurses administered the
questionnaires, and two public health officers supervised
the data collection. Data collectors and supervisors were
trained by the lead author of this paper (AT) for three
days. Topics covered during the training included objec-
tives of the study, interviewing techniques, and practical
exercises. Pilot testing of the questionnaire was done be-
fore in a neighboring village the actual data collection.
Data were collected from May to June 2013.
Table 1 Characteristics of the study participants (n = 393)
Characteristics Number (%)




40.5 (SD = 13.5)
Occupation Farmer 340 (86.5)
Housewife 17 (4.3)
Private business 22 (5.6)
Other 14 (3.6)
Education Can read and write 68 (17.3)
Cannot read and write 325 (82.7)















with others in the
same village
Below average 252 (64.1)
Average 129 (32.8)
Above average 12 (3.1)
Clinical stage Stage I 28 (7.1)
Stage II 239 (60.8)
Stage III 121 (30.8)
Stage IV 4 (1.0)





*Birr is the unit of currency in Ethiopia.
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The raw data were entered and cleaned in EPI INFO
statistics program version 6.04, and analyzed using the
Statistical Package Social Sciences (SPSS) statistics pro-
gram version 16.0. Descriptive statistics was done using
summary statistics such as frequencies, average estimates
(i.e., mean or median), and summary figures. ANOVA,
univariate, and backward stepwise multivariate logistic
regression analyses were performed to model factors
associated with participants’ willingness to pay. The
level of significance was set to be 0.05.
Ethical considerations
Ethical approval for the study was obtained from Debre
Markos University in northern Ethiopia. Support letters
were obtained from the regional and zonal health adminis-
trations. Informed consent was obtained from all study
participants.
Results
Socio-demographic and clinical characteristics of the
study participants
A total of 393 podoconiosis patients participated in the
study (100% response rate). The mean age of the study
participants was 40.5 years (standard deviation [s.d.] =
13.5), 40.7% of the study participants were women, 69.5%
were married, 86.5% were farmers, and 82.7% could not
read and write. The mean family size per household was
5.2 individuals (s.d. = 2.6), and the majority (64.1%) of
the study participants perceived their household’s socio-
economic status to be lower than the village average.
Based on a clinical staging system for podoconiosis [15],
267 (67.9%) participants had early clinical disease (i.e.
stage I or II), and 126 (32.1%) had advanced clinical
disease (i.e., stage III, IV, or V). A total of 78 (19.8%)
study participants said that they had at least one
podoconiosis-affected family member. Half of the study
participants (55% of women and 45.5% of men) were
barefoot during the interview, and 135 study partici-
pants (34.4%; 38.1% of women and 31.8% of men) said
that they had never worn shoes (Table 1).
Perceptions of the study participants about podoconiosis
The majority (65.7%) of the study participants believed
that podoconiosis is caused by evil spirits or did not
know the cause of podoconiosis. Only 34 (8.6%) study
participants mentioned that red clay soil has a causal
association with the development of podoconiosis; the
remaining 91.4% had misconception about the cause of
podoconiosis. A total of 332 (84.5%) study participants
said that podoconiosis is preventable. Of these, most
perceived that podoconiosis can be prevented by avoid-
ing marriage with members of podoconiosis-affected
families (48.8%) or physical contact with podoconiosisaffected individuals (38%). A total of 94 (28.3%) and 92
(27.7%) study participants mentioned that podoconiosis
can be prevented by wearing shoes and washing feet
with soap and water, respectively (Table 2).
Willingness to pay for podoconiosis treatment services
A total of 286 (72.8%) study participants were willing to
pay for podoconiosis treatment services. The study par-
ticipants who chose not to pay (n = 107; 27.2%) said that
they could not afford to pay (93.4%) or had low confi-
dence in the effectiveness of the treatment (6.6%). The
mean household monthly income of study participants
who were not willing to pay was lower than that of par-
ticipants who were willing to pay (212.2 Birr vs. 455.65
Birr; t = −10.39, p < 0.0001). Through the open-ended
Table 2 Perceptions and experiences about podoconiosis
prevention
Question Response Number (%)
What is the cause of
podoconiosis?
Evil Spirit 178 (45.3)
Insect 15 (3.8)
Soil/mud 34 (8.6)
Contact with dirty water 6 (1.5)
Do not know 60 (20.4)
Is podoconiosis preventable? Yes 332 (84.5)
No 61 (15.5)
If the response to the above
question is ‘Yes’: How can
one prevent podoconiosis?
Wearing shoes 94 (28.3)
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son was willing to pay for the treatment services was 64
Birr (US$ 3.28; range: 0–400 Birr or US$ 0–20.51) per
person per year. The demand for treatment services de-
clined as price increased. This decline was slow between
10 Birr (US$ 0.51) and 50 Birr (US$ 2.56) after which it
fell quickly. For example, 59% of the study participants
had a WTP of at least 50 Birr (US$ 2.56), whereas only
31.1% had a WTP of at least 100 Birr (US$ 5.13) (Figure 1).
Over half of the individuals were willing to pay for other
affected family members (Table 3).
Among the study participants who agreed to pay (n =
286), some agreed to pay the full amount (n = 44; 15.4%),
three-fourths the amount (n = 14; 4.9%), or half the
amount (n = 47; 16.4%) of the current IOCC average treat-
ment cost of 330 Birr (US$ 16.92) per person per year.
The cumulative proportions showed that 44 (15.4%), 58





































Willing to pay (price pre
Figure 1 Demand curve for maximum willingness to pay for podoconpay 100%, at least 75%, and at least 50% of the average
treatment cost of IOCC. When asked how much they
would be willing to pay for shoes if other treatment sup-
plies were free, some study participants were willing to
pay the full amount (n = 88; 30.8%), three-fourths the
amount (n = 24; 8.4%) or half the amount (n = 106; 37.1%)
of the current IOCC shoe production cost of 250 Birr
(US$ 12.82) for one person. The cumulative proportions
showed that 88 (30.8%), 112 (39.2%), and 218 (76.2%)
study participants were willing to pay 100%, at least
75%, and at least 50% of the shoe production cost if
other treatment services are provided for free (Table 3).
Factors associated with willingness to pay for
podoconiosis treatment services
Study participants who perceived their households to be
poorer than the village average were willing to pay about
half as much as those who considered their socioeconomic
position average or better (ANOVA F = 36.5, p < 0.0001)
(Figure 2). The multivariate analysis showed that being a
woman, older age, having knowledge that podoconiosis
can be prevented by wearing shoes, possession of a func-
tional radio, higher income, recent history of paying for
treatment services for other conditions, and production of
wheat were associated with increased WTP for podoco-
niosis treatment services (Table 4). There was no statisti-
cally significant difference in WTP between patients with
early and advanced clinical disease stages.
Discussion
In this first study to assess WTP for podoconiosis treat-
ment services, we found that the majority (72.8%) of the
study participants in Baso Liben woreda were willing to
pay. The proportion of individuals willing to pay for
podoconiosis treatment was greater than the proportion
of individuals willing to pay for injectable contraceptives
in Tigray, northern Ethiopia (68%) [16], but lower than
























sented by participants in Birr ) 
iosis treatment services.
Table 3 Willingness to pay for podoconiosis treatment services
Willingness to pay characteristics Number (%) Cumulative number (%)
Willing to pay for podoconiosis treatment services (n = 393)? Yes 286 (72.8) NA
No 107 (27.2) NA
Of those that agreed to pay (n = 286), individuals willing to pay the following: Full cost (330 Birr*) 44 (15.4) 44 (15.4)
3/4th of full cost (248 Birr) 14 (4.9) 58 (20.3)
½ of full cost (165 Birr) 47 (16.4) 105 (36.7)
Willing to pay for shoes if they get treatment supply free (n = 286) Full cost (250 Birr) 88 (30.8) 88 (30.8)
3/4th of full cost (188 Birr) 24 (8.4) 112 (39.2)
½ of full cost (125 Birr) 106 (37.1) 218 (76.3)
Would you be willing to pay for other family members (n = 393)? Yes 218 (55.5) NA
No 175 (44.5) NA
*Birr is the unit of currency in Ethiopia.
NA = not applicable.
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lipid-based nutrient supplements for young children in
four urban sites of Ethiopia (96%) [18]. These differences
may be due to differences in socio-economic and demo-
graphic characteristics of the study populations. Individ-
uals may also perceive malaria and malnutrition more
severe with fatal consequences as compared to podoco-
niosis which is disfiguring, physically disabling, and psy-
chologically and economically traumatizing but not fatal
[6]. Despite these differences, the WTP for podoconiosis
reported in this study is considerably high given the fact
that podoconiosis is a neglected tropical disease that
affects the poor, and the minimal level of awareness and
wide misconceptions about podoconiosis in our study
sample (91.4%) and in a wider study population in northern
Ethiopia [19,20].
The proportion of respondents willing to pay the full
price doubled from 15.4% to 36.7% when the fee re-
quested dropped by half. Furthermore, the proportion of
respondents willing to pay doubled from 36.7% that were
willing to pay at least half IOCC’s cost of full treatment


































Figure 2 Perceived household socio-economic status and mean willinIOCC’s cost of shoes when other treatment services
were given for free. The non-shoe component of podo-
coniosis treatment accounts 24% (80 Birr) of IOCC’s
total treatment cost. Although full cost recovery or full
user fee programs would not be feasible, we have found
that incentives such as free service provision, however
small, influence podoconiosis patients’ WTP for treat-
ment and utilization of the overall treatment package
may be increased. This indicates that partial cost recov-
ery programs could be introduced to increase coverage
of treatment services and to make the integration of
podoconiosis service in the government health system of
Ethiopia more feasible.
Whether an individual was willing to pay for podoco-
niosis was strongly associated with the financial status of
the household. Furthermore, individuals who were not
willing to pay were members of households with half as
much monthly income as compared to those that were
willing to pay. Previous studies have shown that financial
limitation was the primary barrier against consistent use
of footwear among podoconiosis patients [7,8]. The
study participants in our study appeared to have lower84.2
93.3
verage Above Average
conomic position of their household
gness to pay for podoconiosis treatment services.
Table 4 Factors associated with willingness to pay for podoconiosis treatment services
Variable Willing to pay Crude OR Adjusted OR*
Yes No (95% CI) (95% CI)
Sex Male 175 58 1.33 (0.85,2.08) 0.43 (0.19,0.96)¥
Female 111 59 1 1
Educated No 236 89 0.96 (0.53,1.72) 0.44 (0.23,0.56)
Yes 50 18 1 1
Age in years 18-30 85 31 0.69 (0.35,1.34) 0.36 (0.13,0.51)¥
31-38 56 26 0.54 (0.27,1.09) 0.21 (0.07,0.64)¥
39-50 77 33 0.58 (0.29,1.14) 0.36 (0.16,0.71)¥
51-80 68 17 1 1
Monthly income in Birr 100-180 37 48 0.05 (0.02,0.13) 0.16 (0.05,0.50)¥
181-300 57 35 0.10 (0.04,0.28) 0.42 (0.13,0.74)¥
301-500 97 7 0.88 (0.27,2.87) 0.79 (0.63,0.92)¥
501-2500 79 5 1 1
Believed that podoconiosis is preventable by wearing shoes Yes 249 83 1.95 (1.16,3.44) 4.08 (3.45,5.54)¥
No 37 24 1 1
Paid for treatment during the past month Yes 59 14 1.27 (0.92,3.24) 3.45 (1.27,9.34)¥
No 227 93 1 1
Family possessed a functional radio Yes 97 12 4.06 (2.12,7.77) 4.87 (1.89,12.55)¥
No 189 95 1 1
Family harvested wheat Yes 231 54 4.12 (2.55,6.66) 3.79 (1.77,8.11)¥
No 55 55 1 1
Wearing shoes during the interview Yes 204 54 2.44 (1.55,3.85) 2.44 (1.22,4.9)¥
No 82 53 1 1
OR = odds ratio, CI = confidence interval, Ref = reference.
*Adjustment was made for: sex, education, age, monthly income, belief on preventability of podoconiosis, previous history of paying for treatment service,
possession of goat, radio, and donkey, wheat harvesting, wearing shoes during interview.
¥P-value is <0.05.
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spondents (64.1%) perceived that they were poorer than
the village average, and half of the study participants
were barefoot during the interview. Moreover, approxi-
mately twenty percent of the study participants reported
at least one additional podoconiosis-affected household
member, which can lower the economic productivity of
households due to the morbidity from acute adenolym-
phangitis (ALA: hot, tender, painful symptoms in the
lower legs) experienced by affected individuals as reported
by previous studies in northern Ethiopia [19,20].
Several factors influenced WTP of podoconiosis pa-
tients. Factors that were associated with increased WTP
can be generalized under four categories: (i) higher
socio-economic status; (ii) older age, (iii) female sex, and
(iv) more awareness about podoconiosis and modern
health care. First, the positive association between higher
socio-economic status and WTP in our study is supported
by several other studies, showing that people’s WTP be-
havior parallels their ability to pay [21]. Similar findings
have been reported in previous studies conducted inEthiopia on WTP for injectable contraceptives [16] and
insecticide-treated bed nets [17]. Second, older podoco-
niosis patients had greater WTP. This may be because the
onset of podoconiosis is usually in the third decade of life
and the disease advances with age urging patients to seek
health care due to multiple episodes of ALA, limitations
of physical activity, morbidity, and pain [19,20,22-24].
In addition, a study in southern Ethiopia has shown that
because of financial resource barriers in the household,
shoes (the main components of podoconiosis treatment
and prevention) are often purchased for older house-
hold members first rather than for children [25]. Third,
our finding of WTP by more women as compared to
men may be because more women experience ALA in-
cluding more frequent episodes and more bed days per
episode [23]. In the present study, more women than
men were barefoot during the interview (55% vs. 45.5%)
and more women had never worn shoes (38.1% vs.
31.8%) consistent with previous studies showing that
women possessed fewer means to prevent podoconiosis
compared to men [6,14], resulting in a higher demand
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marriage prospects for podoconiosis affected women [5,8]
may be additional social factors that motivate women to
be willing to pay more for treatment than men. Fourth,
factors such as the possession of a functional radio and
previous experience of treatment seeking for other ill-
nesses could enhance awareness about modern health care
and this has also been found to be associated with
increased odds of WTP for insecticide-treated bed
nets [17].
The study participants’ median WTP based on the
open-ended question was approximately twenty percent
of IOCC’s total treatment cost and a quarter of IOCC’s
shoe production cost. The WTP amount declined only
slightly until after the total cost was 15% of IOCC’s total
treatment cost. These findings show new opportunities
to introduce cost-recovery strategies in podoconiosis
treatment programs. The price that is both affordable by
most podoconiosis-affected households and optimal for
cost-recovery should be assessed in program planning.
We acknowledge that there are some limitations to
this study. The sample was selected from the treatment
program waiting list which may have biased results. For
example study participants prior knowledge of IOCC’s
highly subsidized podoconiosis treatment program ser-
vices may have made them less willing to pay which would
have underestimated the WTP amount. An additional
limitation could be related to the representativeness of the
results. WTP could vary by regional cultures and season-
ally, so more research is needed to explore WTP which
could be used in the national NTD programming and
policy planning. The findings of this study needs to be
validated using qualitative study methods, in socio-
culturally and economically diverse areas in Ethiopia,
and at different seasons of the year because individuals’
WTP varies with season as the majority of the study
participants are farmers. Moreover, we have not assessed
the test-retest reliability of the CVM due to resource and
time constraints.
This study can serve as a foundation for future stud-
ies to set a price threshold for podoconiosis treatment
services in both governmental and non-governmental
facilities. For podoconiosis affected households that
are not able to afford and not willing to pay, selective
fee waiver certification could be introduced. A fee-waiver
and exemption system is currently institutionalized in
Ethiopia’s government health service institutions for es-
sential health care services [26], and this can be adapted
for podoconiosis treatment.
Conclusions
This study showed a significant potential for introducing
a cost-recovery system that could increase podoconiosis
treatment service utilization and reduce the backlog ofpatients in the waiting list of IOCC due to inadequacy
of resources. In Ethiopia, less than four percent of esti-
mated podoconiosis patients have access to treatment
[11]. Therefore, the promotion of self-financing could
enhance the sustainability of treatment in podoconiosis
programs or integrated initiatives such as morbidity
management with filarial lymphedema. A subsidized cost-
recovery scheme could reduced treatment costs and more
feasibly integrate podoconiosis treatment services with
other NTDs and the government’s primary health care
system.
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